Treatment of secondary hyperparathyroidism in ESRD: a 2-year, single-center crossover study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of secondary hyperparathyroidism in ESRD: a 2-year, single-center crossover study

Published:2010-08 Issue: Volume:78 Page:S33-S36
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Mittman Neal,Desiraju Brinda,Meyer Kevin B.,Chattopadhyay Jyoti,Avram Morrell M.

Publisher

Elsevier BV

Subject

Nephrology

Reference34 articles.

1. Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease;Khan;Am J Med Sci,2007

2. The parathyroid-calcitriol axis in health and chronic renal failure;Slatopolsky;Kidney Int,1986

3. Consequences and management of hyperphosphatemia in patients with renal insufficiency;Friedman;Kidney Int,2005

4. Secondary hyperparathyroidism in chronic kidney disease: clinical consequences and challenges;Michael;Nephrol Nurs J,2004

5. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis;Block;N Engl J Med,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Paricalcitol and Calcitriol with or without Calcimimetics on Pulse Wave Velocity and Serum Levels for Parathyroid Hormone, Calcium and Phosphorus in Maintenance Hemodialysis Patients;Acta Endocrinologica (Bucharest);2023

2. Research progress in the pharmacological actions of the multiple effects and selectivity of the vitamin D analogue paricalcitol: a narrative review;Annals of Palliative Medicine;2021-10

3. Real-world evidence and optimization of vocal dysfunction in end-stage renal disease patients with secondary hyperparathyroidism;Scientific Reports;2021-01-12

4. Paricalcitol vs. cinacalcet for secondary hyperparathyroidism in chronic kidney disease: A meta-analysis;Experimental and Therapeutic Medicine;2020-07-24

5. Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison;Frontiers in Endocrinology;2019-02-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3